Literature DB >> 1141218

The activation of coagulation factor X. Identity of cleavage sites in the alternative activation pathways and characterization of the COOH-terminal peptide.

J Jesty, A K Spencer, Y Nakashima, Y Nemerson, W Konigsberg.   

Abstract

Bovine Factor X can be activated by two alternative pathways. The first, favored at high concentrations of the complex of tissue factor and Factor VII, is initiated by the action of Factor VII on Factor X to cleave an activation peptide from the NH2 terminus of the heavy chain, to produce alpha-Xa. This is then converted autocatalytically to another form of Factor Xa, beta-Xa, by the loss of a 17-residue glycopeptide from the COOH terminus of the heavy chain, in a lipid-dependent reaction. The alternative pathway, favored at lower activator concentrations, is initiated by the action of Factor Xa on Factor X, in the presence of lipid, to release the same COOH-terminal peptide as is produced in the conversion of alpha-Xa to beta-Xa. The intermediate produced by the loss of this peptide from Factor X,I1, can be activated directly to beta-Xa by the tissue factor-Factor VII complex, with the loss of the same NH2-terminal peptide as is produced in the conversion of Factor X to alpha-Xa. The autocatalytic activation of Factor X by Factor Xa described previously occurs to a marked extent only at very low activator concentrations, and has been shown to proceed largely by the loss of the normal NH2-terminal peptide from the heavy chain of I1-Initial experiments show that neither peptide affects the rate of coagulation by either the extrinsic or intrinsic pathways. The amino acid sequences have been determined on both sides of the peptide cleavages, and it has been shown that the cleavage sites are the same, regardless of the pathway of activation. The amino acid sequence and carbohydrate composition of the COOH-terminal peptide have been determined. The carbohydrate moiety is attached via an O-glycosidic linkage at a threonine residue, and contains galactosamine but no glucosamine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Proteolytic inactivation of tissue factor pathway inhibitor by bacterial omptins.

Authors:  Thomas H Yun; Jessica E Cott; Richard I Tapping; James M Slauch; James H Morrissey
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

2.  Cloning and comparison of factor X from rhesus monkey (Macaca mulatta).

Authors:  Younan Chen; Shengfang Qin; Weidong Tan; Yanrong Lu; Jie Zhang; Hongxia Li; Hong Bu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-10       Impact factor: 0.982

3.  Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites.

Authors:  Narender Singh; James M Briggs
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

4.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization.

Authors:  Rinku Majumder; Jianfang Wang; Barry R Lentz
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

5.  Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system.

Authors:  S D Forman; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

7.  Expression analysis of tissue factor pathway inhibitors TFPI-1 and TFPI-2 in Paralichthys olivaceus and antibacterial and anticancer activity of derived peptides.

Authors:  Guanghua Wang; Bing Xie; Yanli Su; Qinqin Gu; Dongfang Hao; Hongmei Liu; Changbiao Wang; Yonghua Hu; Min Zhang
Journal:  Vet Res       Date:  2021-02-25       Impact factor: 3.683

8.  A mutated factor X activatable by thrombin corrects bleedings in vivo in a rabbit model of antibody-induced hemophilia A.

Authors:  Toufik Abache; Alexandre Fontayne; Dominique Grenier; Emilie Jacque; Alain Longue; Anne-Sophie Dezetter; Béatrice Souilliart; Guillaume Chevreux; Damien Bataille; Sami Chtourou; Jean-Luc Plantier
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.